Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Artemisinic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103172645A details a scalable route from artemisinic acid. Offers high yield and purity for API intermediates. Ideal for pharmaceutical supply chains.
Patent CN101857613A reveals a novel PTC synthesis for anti-influenza rupestonic acid esters, offering cost reduction in API manufacturing and scalable production.
Patent CN103172645B details a robust artemisinin synthesis route offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN102612507A reveals a diimine hydrogenation process for artemisinin intermediates, offering cost reduction and high stereoselectivity for pharmaceutical manufacturing.